Home › Sanofi profit soars on lower Lemtrada charge
 

Keywords :   


Sanofi profit soars on lower Lemtrada charge

2015-02-05 09:10:43| Biotech - Topix.net

Sanofi SA says its net profit soared 26.3 percent in the fourth quarter thanks to lower charges against Lemtrada, its multiple sclerosis treatment. The world's third-largest drugmaker by sales reported net profit of 1.34 billion in the period.

Tags: lower charge profit sanofi

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »